Search Within

Stephanie Anne Fish

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
  3. Book Section (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (9)
  2. Department of Medicine (9)
  3. Division of Subspecialty Medicine (9)
  4. Endocrinology (9)
  5. GSK Faculty (9)
  6. Human Oncology and Pathogenesis Program (9)

More Groups

People
  1. James Fagin (9)
  2. Robert Tuttle (8)
  3. Laura Boucai (7)
  4. Mona Sabra (7)
  5. Ronald Ghossein (6)
  6. Alan Ho (5)

More People

Years
  1. 2022 (3)
  2. 2020 (1)
  3. 2019 (1)
  4. 2017 (1)
  5. 2016 (2)
  6. 2011 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Thyroid (3)
  3. JAMA Otolaryngology - Head and Neck Surgery (1)
  4. Journal of Clinical Endocrinology and Metabolism (1)
  5. Thyroid Cancer: A Comprehensive Guide to Clinical Management. 3rd ed (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Mary Ann Liebert, Inc (3)
  3. American Medical Association (1)
  4. Oxford University Press (1)
  5. Springer (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Active surveillance of papillary thyroid cancer: Frequency and time course of the six most common tumor volume kinetic patterns
    Journal Article

    Tuttle, R. M.; Fagin, J.; Minkowitz, G.; Wong, R.; Roman, B.; Patel, S.; Untch, B.; Ganly, I.; Shaha, A.; Shah, J.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance
    Journal Article

    Tuttle, R. M.; Fagin, J. A.; Minkowitz, G.; Wong, R. J.; Roman, B.; Patel, S.; Untch, B.; Ganly, I.; Shaha, A. R.; Shah, J. P.; more...
    JAMA Otolaryngology - Head and Neck Surgery (2017)

    Fulltext@MSK | Save
  • Radioiodine-refractory thyroid cancer: Restoring response to radioiodine therapy
    Book Section

    Fish, S. A.; Fagin, J. A.
    In Wartofsky, L.; Van Nostrand, D. (Eds.) Thyroid Cancer: A Comprehensive Guide to Clinical Management. 3rd ed (2016)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression
    Journal Article

    Rondeau, G.; Fish, S.; Hann, L. E.; Fagin, J. A.; Tuttle, R. M.
    Thyroid (2011)

    Fulltext@MSK | Save